CHDH and breast carcinoma: In the present study, to determine whether CDH family members can serve as suitable biomarkers for breast cancer and pathways related to the EMT and metastasis, comprehensive integrative data mining was utilized, including gene expressions, survival analyses, clinical and pathological factors, immune infiltration, and enrichment pathway analyses.